Abstract
Norman E. “Ned” Sharpless, director of the US National Cancer Institute (NCI), will serve as acting commissioner of the US Food and Drug Administration after current chief Scott Gottlieb departs the agency next month. Gottlieb announced his resignation on March 5, saying he wants to spend more time with his wife and children, who live in Connecticut. Sharpless joined NCI in October 2017. During his short time at the institute, Sharpless worked to enhance data sharing and modernize clinical trials for new cancer treatments. He also led a group studying how the aging process leads to cancer in genetically engineered mice. Sharpless came to NCI with experience in academia as well as industry. He had served on the faculty of the University of North Carolina School of Medicine and directed the UNC Lineberger Comprehensive Cancer Center. He also cofounded two biotech companies to develop cancer drugs (G1 Therapeutics) and diagnostics
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
